{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:23:11Z","timestamp":1786980191771,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06560-4","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:27:52Z","timestamp":1763548072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Economic evidence on the cost-effectiveness of newborn screening for spinal muscular atrophy: a systematic review"],"prefix":"10.1007","volume":"184","author":[{"given":"Amit Kumar","family":"Mittal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolat Singh","family":"Shekhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Amrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"6560_CR1","doi-asserted-by":"crossref","unstructured":"Burr P, Reddivari AKR (2020) Spinal muscle atrophy. Pediatr Clin N Am 62 (2015) 743\u2013766","DOI":"10.1016\/j.pcl.2015.03.010"},{"key":"6560_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/B978-0-323-98818-6.00031-5","volume":"195","author":"DS Younger","year":"2023","unstructured":"Younger DS (2023) Critical illness\u2013associated weakness and related motor disorders. Handb Clin Neurol 195:707\u2013777","journal-title":"Handb Clin Neurol"},{"key":"6560_CR3","unstructured":"Emmady PD, Bodle J (2020) Werdnig-Hoffmann disease. Treasure island (FL): StatPearls Publishing, 2025 Jan"},{"key":"6560_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IE Verhaart","year":"2017","unstructured":"Verhaart IE, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, Cook SF, Lochm\u00fcller H (2017) Prevalence, incidence and carrier frequency of 5q\u2013linked spinal muscular atrophy\u2013a literature review. Orphanet J Rare Dis 12:1\u201315","journal-title":"Orphanet J Rare Dis"},{"key":"6560_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241511939","volume":"24","author":"H Nishio","year":"2023","unstructured":"Nishio H, Niba ETE, Saito T, Okamoto K, Takeshima Y, Awano H (2023) Spinal muscular atrophy: the past, present, and future of diagnosis and treatment. Int J Mol Sci 24:11939","journal-title":"Int J Mol Sci"},{"key":"6560_CR6","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4161\/rna.8.4.16224","volume":"8","author":"NN Singh","year":"2011","unstructured":"Singh NN, Singh RN (2011) Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model. RNA Biol 8:600\u2013606","journal-title":"RNA Biol"},{"key":"6560_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.12.006","author":"F Moultrie","year":"2025","unstructured":"Moultrie F, Chiverton L, Hatami I, Lilien C, Servais L (2025) Pushing the boundaries: future directions in the management of spinal muscular atrophy. Trends Mol Med. https:\/\/doi.org\/10.1016\/j.molmed.2024.12.006","journal-title":"Trends Mol Med"},{"key":"6560_CR8","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s00431-023-04883-8","volume":"182","author":"L Antonaci","year":"2023","unstructured":"Antonaci L, Pera MC, Mercuri E (2023) New therapies for spinal muscular atrophy: where we stand and what is next. Eur J Pediatr 182:2935\u20132942","journal-title":"Eur J Pediatr"},{"key":"6560_CR9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s40263-021-00878-x","volume":"35","author":"SM Hoy","year":"2021","unstructured":"Hoy SM (2021) Nusinersen: a review in 5q spinal muscular atrophy. CNS Drugs 35:1317\u20131328","journal-title":"CNS Drugs"},{"key":"6560_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41436-019-0673-0","volume":"22","author":"D Kariyawasam","year":"2020","unstructured":"Kariyawasam D, Russell JS, Wiley V, Alexander IE, Farrar MA (2020) The implementation of newborn screening for spinal muscular atrophy: the Australian experience. Genet Med 22:557\u2013565","journal-title":"Genet Med"},{"key":"6560_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijns10030049","volume":"10","author":"K Cooper","year":"2024","unstructured":"Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A, Bessey A (2024) Systematic review of newborn screening programmes for spinal muscular atrophy. Int J Neonatal Screen 10:49","journal-title":"Int J Neonatal Screen"},{"key":"6560_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/gtmb.2023.0073","volume":"28","author":"DS Shekhawat","year":"2024","unstructured":"Shekhawat DS, Didel S, Dixit SG, Singh P, Singh K (2024) Carrier screening and diagnosis for spinal muscular atrophy using droplet digital PCR versus MLPA: analytical validation and early test outcome. Genet Test Mol Biomarkers 28:207\u2013212","journal-title":"Genet Test Mol Biomarkers"},{"key":"6560_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-024-05953-1","volume":"184","author":"H Saito","year":"2025","unstructured":"Saito H, Sakai K, Tanaka M, Konomura K, Suzuki M, Tajima G, Hoshino E (2025) Economic evaluation of newborn screening for congenital cytomegalovirus infection: a systematic review. Eur J Pediatr 184:123","journal-title":"Eur J Pediatr"},{"key":"6560_CR14","doi-asserted-by":"crossref","unstructured":"Pace AC, Poon C, Chakraborty P, Oskoui M, McMillan H, Mackenzie A\u00a0(2025) Round J. Systematic review for economic evaluations on newborn screening for spinal muscular atrophy. Journal of neuromuscular diseases. May 22:22143602251336862","DOI":"10.1186\/s13023-025-03927-6"},{"key":"6560_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00431-017-3046-1","volume":"177","author":"MO Blanken","year":"2018","unstructured":"Blanken MO, Frederix GW, Nibbelke EE, Koffijberg H, Sanders EA, Rovers MM, Bont L, Network DRN (2018) Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants. Eur J Pediatr 177:133\u2013144","journal-title":"Eur J Pediatr"},{"key":"6560_CR16","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/jnnp-2021-326344","volume":"92","author":"ST Shih","year":"2021","unstructured":"Shih ST, Farrar MA, Wiley V, Chambers G (2021) Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis. J Neurol Neurosurg Psychiatry 92:1296\u20131304","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6560_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1177\/22143602241288095","volume":"11","author":"E Vr\u0161\u010daj","year":"2024","unstructured":"Vr\u0161\u010daj E, Dangouloff T, Osredkar D, Servais L, Group SNWS (2024) Newborn screening programs for spinal muscular atrophy worldwide in 2023. J Neuromuscul Dis 11:1180\u20131189","journal-title":"J Neuromuscul Dis"},{"key":"6560_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijns10030058","volume":"10","author":"CM Zaidman","year":"2024","unstructured":"Zaidman CM, Crockett CD, Wedge E, Tabatabai G, Goedeker N (2024) Newborn screening for spinal muscular atrophy: variations in practice and early management of infants with spinal muscular atrophy in the United States. Int J Neonatal Screen 10:58","journal-title":"Int J Neonatal Screen"},{"key":"6560_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03697-1","volume":"20","author":"C-H Wang","year":"2025","unstructured":"Wang C-H, Hsu T-R, Liu M-Y, Wang L-Y, Chou I-J, Lee W-T, Liang W-C, Lee I-C, Chen H-J, Kao S-M (2025) Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan. Orphanet J Rare Dis 20:197","journal-title":"Orphanet J Rare Dis"},{"key":"6560_CR20","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1007\/s00431-024-05735-9","volume":"183","author":"M Pane","year":"2024","unstructured":"Pane M, Stanca G, Coratti G, D\u2019Amico A, Sansone VA, Berti B, Fanelli L, Albamonte E, Ausili Cefaro C, Cerchiari A (2024) Prognostic factors for tube feeding in type I SMA patients treated with disease-modifying therapies: a cohort study. Eur J Pediatr 183:4735\u20134745","journal-title":"Eur J Pediatr"},{"key":"6560_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/genes14071377","volume":"14","author":"K Aragon-Gawinska","year":"2023","unstructured":"Aragon-Gawinska K, Mouraux C, Dangouloff T, Servais L (2023) Spinal muscular atrophy treatment in patients identified by newborn screening\u2014a systematic review. Genes 14:1377","journal-title":"Genes"},{"key":"6560_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2025.02.012","author":"M Patel","year":"2025","unstructured":"Patel M, Goel AD, Saini L, Kaushal R, Mathur D, Mittal AK, Rajial T, Singh K (2025) Prevalence of pediatric and adolescent epilepsy in India: a systematic review and meta-analysis. Seizure. https:\/\/doi.org\/10.1016\/j.seizure.2025.02.012","journal-title":"Seizure"},{"key":"6560_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/13696998.2024.2439734","volume":"28","author":"A Hata","year":"2025","unstructured":"Hata A, Uda A, Tanaka S, Weidlich D, Toro W, Schmitt L, Igarashi A, Bischof M (2025) Cost-utility analysis of newborn screening for spinal muscular atrophy in Japan. J Med Econ 28:44\u201353","journal-title":"J Med Econ"},{"key":"6560_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s40261-024-01386-8","volume":"44","author":"G Ghetti","year":"2024","unstructured":"Ghetti G, Mennini FS, Marcellusi A, Bischof M, Pistillo GM, Pane M (2024) Cost-effectiveness analysis of newborn screening for spinal muscular atrophy in Italy. Clin Drug Investig 44:687\u2013701","journal-title":"Clin Drug Investig"},{"key":"6560_CR25","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jval.2022.06.010","volume":"25","author":"R Velikanova","year":"2022","unstructured":"Velikanova R, van der Schans S, Bischof M, van Olden RW, Postma M, Boersma C (2022) Cost-effectiveness of newborn screening for spinal muscular atrophy in The Netherlands. Value Health 25:1696\u20131704","journal-title":"Value Health"},{"key":"6560_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.nmd.2023.11.013","volume":"34","author":"T Dangouloff","year":"2024","unstructured":"Dangouloff T, Thokala P, Stevenson MD, Deconinck N, D\u2019Amico A, Daron A, Delstanche S, Servais L, Hiligsmann M (2024) Cost-effectiveness of spinal muscular atrophy newborn screening based on real-world data in Belgium. Neuromuscul Disord 34:61\u201367","journal-title":"Neuromuscul Disord"},{"key":"6560_CR27","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s40120-023-00489-2","volume":"12","author":"D Weidlich","year":"2023","unstructured":"Weidlich D, Servais L, Kausar I, Howells R, Bischof M (2023) Cost-effectiveness of newborn screening for spinal muscular atrophy in England. Neurol Ther 12:1205\u20131220","journal-title":"Neurol Ther"},{"key":"6560_CR28","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s40120-025-00744-8","volume":"14","author":"IR Woodcock","year":"2025","unstructured":"Woodcock IR, Kariyawasam DS, Kava MP, Yiu EM, Clark D, Adams J, Bischof M, Peacock A, Taylor C, Smith NJ (2025) Cost-effectiveness of newborn screening for spinal muscular atrophy in Australian hospitals. Neurol Ther 14:1007\u20131022","journal-title":"Neurol Ther"},{"key":"6560_CR29","doi-asserted-by":"publisher","first-page":"238146832110610","DOI":"10.1177\/23814683211061097","volume":"7","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E (2022) Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. MDM Policy & Practice 7:23814683211061096","journal-title":"MDM Policy & Practice"},{"key":"6560_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/01.mop.0000133635.79661.84","author":"P Rinaldo","year":"2004","unstructured":"Rinaldo P, Tortorelli S, Matern D (2004) Recent developments and new applications of tandem mass spectrometry in newborn screening. Curr Opin Pediatr. https:\/\/doi.org\/10.1097\/01.mop.0000133635.79661.84","journal-title":"Curr Opin Pediatr"},{"key":"6560_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10545-011-9326-4","volume":"34","author":"B Wilcken","year":"2011","unstructured":"Wilcken B (2011) Newborn screening: how are we travelling, and where should we be going? J Inherit Metab Dis 34:569\u2013574","journal-title":"J Inherit Metab Dis"},{"key":"6560_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/1073110516654133","volume":"44","author":"N Kelly","year":"2016","unstructured":"Kelly N, Makarem DC, Wasserstein MP (2016) Screening of newborns for disorders with high benefit-risk ratios should be mandatory. J Law Med Ethics 44:231\u2013240","journal-title":"J Law Med Ethics"},{"key":"6560_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/00313020701813743","volume":"40","author":"B Wilcken","year":"2008","unstructured":"Wilcken B, Wiley V (2008) Newborn screening. Pathology 40:104\u2013115","journal-title":"Pathology"},{"key":"6560_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/MOP.0000000000000683","volume":"30","author":"BL Therrell Jr","year":"2018","unstructured":"Therrell BL Jr, Padilla CD (2018) Newborn screening in the developing countries. Curr Opin Pediatr 30:734\u2013739","journal-title":"Curr Opin Pediatr"},{"key":"6560_CR35","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s40883-021-00243-w","volume":"8","author":"K Lee","year":"2022","unstructured":"Lee K, Brayboy L, Tripathi A (2022) Pre-eclampsia: a scoping review of risk factors and suggestions for future research direction. Regen Eng Transl Med 8:394\u2013406","journal-title":"Regen Eng Transl Med"},{"key":"6560_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-024-03689-0","author":"M Mori","year":"2024","unstructured":"Mori M, Chaudhari BP, Ream MA, Kemper AR (2024) Promises and challenges of genomic newborn screening (NBS)\u2013lessons from public health NBS programs. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-024-03689-0","journal-title":"Pediatr Res"},{"key":"6560_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jpeds.2020.07.033","volume":"227","author":"A Jalali","year":"2020","unstructured":"Jalali A, Rothwell E, Botkin JR, Anderson RA, Butterfield RJ, Nelson RE (2020) Cost-effectiveness of nusinersen and universal newborn screening for spinal muscular atrophy. J Pediatr 227:274\u2013280.e272","journal-title":"J Pediatr"},{"key":"6560_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijns8030045","volume":"8","author":"ST Shih","year":"2022","unstructured":"Shih ST, Keller E, Wiley V, Farrar MA, Wong M, Chambers GM (2022) Modelling the cost-effectiveness and budget impact of a newborn screening program for spinal muscular atrophy and severe combined immunodeficiency. Int J Neonatal Screen 8:45","journal-title":"Int J Neonatal Screen"},{"issue":"124\u2013129","key":"6560_CR39","volume":"190","author":"Y-H Chien","year":"2017","unstructured":"Chien Y-H, Chiang S-C, Weng W-C, Lee N-C, Lin C-J, Hsieh W-S, Lee W-T, Jong Y-J, Ko T-M, Hwu W-L (2017) Presymptomatic diagnosis of spinal muscular atrophy through newborn screening. J Pediatr 190(124\u2013129):e121","journal-title":"J Pediatr"},{"key":"6560_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12519-019-00242-6","volume":"15","author":"Q Ke","year":"2019","unstructured":"Ke Q, Zhao Z-Y, Mendell JR, Baker M, Wiley V, Kwon JM, Alfano LN, Connolly AM, Jay C, Polari H (2019) Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr 15:219\u2013225","journal-title":"World J Pediatr"},{"key":"6560_CR41","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","volume":"29","author":"C Darryl","year":"2019","unstructured":"Darryl C, Bertini E, Swoboda KJ, Hwu W-L, Crawford TO, Finkel RS, Kirschner J, Kuntz NL, Parsons JA, Ryan MM (2019) Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the phase 2 nurture study. Neuromuscul Disord 29:842\u2013856","journal-title":"Neuromuscul Disord"},{"key":"6560_CR42","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, Lowes L, Alfano L, Berry K, Church K (2017) Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med 377:1713\u20131722","journal-title":"N Engl J Med"},{"key":"6560_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.25259\/JNRP_312_2024","volume":"16","author":"DS Shekhawat","year":"2025","unstructured":"Shekhawat DS, Mittal AK, Singh K, Singh P, Sharma C, Kaur SD, Didel S, Dixit S (2025) Cost estimation for spinal muscular atrophy diagnosis using multiplex ligation-dependent probe amplification and droplet digital polymerase chain reaction. J Neurosci Rural Pract 16:271\u2013279","journal-title":"J Neurosci Rural Pract"},{"key":"6560_CR44","volume":"43","author":"DS Shekhawat","year":"2025","unstructured":"Shekhawat DS, Mittal A, Singh K (2025) Cost analysis of newborn screening for spinal muscular atrophy using digital PCR vs. MLPA. Mol Genet Metab Rep 43:101234","journal-title":"Mol Genet Metab Rep"},{"key":"6560_CR45","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/JND-221561","volume":"9","author":"J Matteson","year":"2022","unstructured":"Matteson J, Wu CH, Mathur D, Tang H, Sciortino S, Feuchtbaum L, Bishop T, Sharma SC, Neogi P, Fitzgibbon I (2022) California\u2019s experience with SMA newborn screening: a successful path to early intervention. J Neuromuscul Dis 9:777\u2013785","journal-title":"J Neuromuscul Dis"},{"key":"6560_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03362-z","volume":"19","author":"R Trollmann","year":"2024","unstructured":"Trollmann R, Johannsen J, Vill K, K\u00f6hler C, Hahn A, Illsinger S, Pechmann A, Hagen M, M\u00fcller-Felber W (2024) Postnatal management of preterm infants with spinal muscular atrophy: experience from German newborn screening. Orphanet J Rare Dis 19:353","journal-title":"Orphanet J Rare Dis"},{"key":"6560_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/genes14122211","volume":"14","author":"S Sonehara","year":"2023","unstructured":"Sonehara S, Bo R, Nambu Y, Iketani K, Lee T, Shimomura H, Ueda M, Takeshima Y, Iijima K, Nozu K (2023) Newborn screening for spinal muscular atrophy: a 2.5-year experience in Hyogo Prefecture, Japan. Genes 14:2211","journal-title":"Genes"},{"key":"6560_CR48","doi-asserted-by":"publisher","DOI":"10.15844\/pedneurbriefs-33-5","volume":"33","author":"M Lopez-Chacon","year":"2019","unstructured":"Lopez-Chacon M, Buehner AN, Rao VK (2019) Spinal muscular atrophy diagnosed by newborn screening. Pediatr Neurol Briefs 33:5","journal-title":"Pediatr Neurol Briefs"},{"key":"6560_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijns10030057","volume":"10","author":"M Brku\u0161anin","year":"2024","unstructured":"Brku\u0161anin M, Garai N, Karanovi\u0107 J, \u0160ljivan\u010danin Jakovljevi\u0107 T, Dimitrijevi\u0107 A, Jovanovi\u0107 K, Mitrovi\u0107 TL, Mikovi\u0107 \u017d, Braju\u0161kovi\u0107 G, Nikoli\u0107 DM, Savi\u0107-Pavi\u0107evi\u0107 D (2024) Our journey from individual efforts to nationwide support: implementing newborn screening for spinal muscular atrophy in Serbia. Int J Neonatal Screen 10:57","journal-title":"Int J Neonatal Screen"},{"key":"6560_CR50","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.14.138206","author":"J Kahn","year":"2015","unstructured":"Kahn J, Marseille E, Larson B, Kazi D, Kahn J, Rosen S (2015) Thresholds for the cost\u2013effectiveness of interventions: alternative approaches. Bull World Health Organ. https:\/\/doi.org\/10.2471\/BLT.14.138206","journal-title":"Bull World Health Organ"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06560-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06560-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06560-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:03:56Z","timestamp":1768460636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06560-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6560"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06560-4","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"774"}}